Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
Completed · Phase 4
Conditions studied: Schizophrenia, Schizoaffective Disorder, Social Anxiety Disorder
In brief
This study will determine the efficacy of a medication switch to Aripiprazole for the treatment of schizophrenia or schizoaffective disorder in patients with moderate to high symptoms of social anxiety. Specifically the study will test the possibility that a medication switch to Aripiprazole reduces symptoms of social anxiety in this patient population.
Key facts
- Study ID
- NCT00177008
- Run by
- University of Medicine and Dentistry of New Jersey
- People needed
- 18
- Starts
- 2004-03-01
- Expected to finish
- 2007-01-01
- Last updated by the study team
- 2007-01-29
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients meeting DSM IV diagnostic criteria for schizophrenia or schizoaffective disorder.
- Patients presenting with comorbid social anxiety symptoms of moderate to high severity are eligible for participation in the study. Only patients with LSAS scores above 30* qualify for the study.
- Age 18-65
- Gender: males or females
- Females: non-pregnant, not of child-bearing potential; if of child-bearing age must be on contraceptive such as pill or shot (condom alone not sufficient)
- Good general health
You may not qualify if…
- Patient does not meet DSM IV diagnostic criteria for schizophrenia or schizoaffective disorder
- Patient carries a diagnosis of dementia, degenerative CNS disorders, mental retardation, substance abuse or dependence other than nicotine dependence or alcohol abuse will be excluded from the study.
- Patients with acute medical conditions are not eligible.
- Patients allergic or otherwise intolerant or non-responsive to Aripiprazole
- Patient with history of suicidal, homicidal or assaultive plans or attempts in the past 6 months.
- Clinically significant EKG or lab abnormalities
Where it is running
- Robert Wood Johnson Medical School - Psychiatry Dept. — Piscataway, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.